Identification of predictors for lower extremity vein graft stenosis

American Journal of Surgery

Volumn 174, Issue 2, 1997, Pages 218-221

  Gentile, Andrew T ^a   Mills, Joseph L ^a   Gooden, Michael A ^a   Westerband, Alex ^a   Haiyan, Cui ^a   Berman, Scott S ^a   Hunter, Glenn C ^a   Hughes, John D ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BLOOD FLOW; BYPASS SURGERY; CONFERENCE PAPER; ECHOGRAPHY; FEMALE; GRAFT OCCLUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VEIN GRAFT;

AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; LEG; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SMOKING; TRANSPLANTATION, AUTOLOGOUS; VASCULAR PATENCY; VEINS;

EID: 0030868753     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(97)00087-1     Document Type: Conference Paper

References (26)

1. Szilagyi DE, Elliot JP, Hagemann JH, et al. Biologic fate of autogenous vein implants as arterial substitutes: clinical, angiographic, and histopathologic observations in femoro-popliteal operations for atherosclerosis. Ann Surg. 1973;178:232-246.
2. Mills JL, Bandyk DF, Gahtan V, Esses GE. The origin of infrainguinal vein graft stenosis: a prospective study based on duplex surveillance. J Vasc Surg. 1995;21:16-25.
3. Taylor PR, Wolfe JHN, Tyrrell MR, et al. Graft stenosis-justification for 1-year surveillance. Br J Surg. 1990;77:1125-1128.
4. Erickson CA, Towne JB, Seabrook GR, et al. Ongoing vascular laboratory surveillance is essential to maximize long-term in situ saphenous vein bypass patency. J Vasc Surg. 1996;23:18-27.
5. Nehler MR, Moneta GL, Yeager RA, et al. Surgical treatment of threatened reversed infrainguinal vein grafts. J Vasc Surg. 1994;20:558-565.
6. Mills JL. The impact of duplex surveillance on infrainguinal bypass surgery. Advanc Vasc Surg. 1996;4:201-210.
7. Sumner DS, Mattos MA, Hodgson KJ. Surveillance program for vascular reconstructive procedures. In: Yao JST, Pearce WH, eds. Long-term Results in Vascular Surgery. Norwalk, Conn: Appleton & Lange; 1993:33-59.
8. Mattos MA, Van Bemmelin PS, Hodgson KJ, et al. Does correction of stenoses identified with color duplex scanning improve infrainguinal graft patency? J Vasc Surg. 1992;15:1059. Abstract.
9. Idu MM, Blankenstein JD, de Gier P, et al. Impact of a color-flow duplex surveillance program on infrainguinal vein graft patency: a five-year experience. J Vasc Surg. 1993;17:42-53.
10. Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery. J Vasc Surg. 1986;4:80-94.
11. Westerband A, Mills JL, Marek JM, et al. Immunocytochemical determination of cell type and proliferation rate in human vein graft stenoses. J Vasc Surg. 1997;25:64-67.
12. Whittemore AD, Clowes AW, Couch NP, Mannick JA. Secondary femoropopliteal reconstruction. Ann Surg. 1981;193:35-42.
13. Mills JL, Fujitani RM, Taylor SM. The characteristics and anatomic distribution of lesions that cause reversed vein graft failure: a five-year prospective study. J Vasc Surg. 1993;17:195-206.
14. Gentile AT, Lee RW, Moneta GL, et al. Results of bypass to the popliteal and tibial arteries with alternative sources of autogenous vein. J Vasc Surg. 1996;23:272-280.
15. Fowkes FGR. The aetiology of peripheral atherosclerosis. BMJ. 1989;298:405-406.
16. Balkau B, Vray M, Eschwege E. Epidemiology of peripheral arterial disease. J Cardiovasc Pharm. 1994;23(suppl 3):8S-16S.
17. Lakier JB. Smoking and cardiovascular disease. Am J Med. 1992;93(1A):8S-12S.
18. Novo S, Avellone G, DiGarbo V, et al. Prevalence of risk factors in patients with peripheral arterial disease. A clinical and epidemiological evaluation. Int Angio. 1992;11:218-229.
19. Lee AJ, Fowkes FG, Rattray A, et al. Hemostatic and rheological factors in intermittent claudication: the influence of smoking and extent of arterial disease. Brit J Haemat. 1996;92(1):226-230.
20. Newman AB, Siscovick DS, Manolio TA, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation. 1993;88:837-845.
21. Cooke JP, Ma AO. Medical therapy of peripheral arterial occlusive disease. In: Gerwertz BL, ed. Surgical Clinics of North America. Philadelphia: WB Saunders; 1995;75:569-579.
22. Powell JT, Higman D, Greenhalgh RM. Smoking and its influence on graft patency. In: Yao J, Pearce W, eds. Long-term Results in Vascular Surgery. Norwalk, Conn: Appleton & Lange; 1993:9-17.
23. Cheshire NJ, Wolfe JH, Barradas MA, et al. Smoking and plasma fibrinogen, lipoprotein a and serotonin are markers for postoperative infrainguinal graft stenosis. Euro J Vasc Endovasc Surg. 1996;11:479-486.
24. Wiseman S, Kenchington G, Dain R, et al. Influence of smoking and plasma factors on femoropopliteal vein graft patency. BMJ. 1989;299:643-646.
25. Meade TW, Iverson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risks of ischemic heart disease. Lancet. 1987;ii:986-988.
26. Higman DJ, Strachan AMJ, Buttery L, et al. Smoking impairs the activity of endothelial nitric oxide synthase in saphenous vein. Arterioscler Thromb Vasc Biol. 1996;16:546-552.